UroToday1d
SES AUA 2025: PSA Dynamics from the Phase 3 EMBARK Trial: A Post Hoc Analysis
SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Paul Sieber discussing a post hoc analysis ...
Medscape3d
Increasing, Persistent PSA Levels Linked to Higher All-Cause Mortality
Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause ...
Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests
After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.
UroToday3d
SES AUA 2025: Survival Outcomes of Radical Prostatectomy versus Dose-Escalated Radiation with ADT in Node-Positive Prostate Cancer
SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Arjun Pon Avudaiappan discussing survival ...